DIN 02515296 — CYTARABINE INJECTION 100 MG
CYTARABINE INJECTION is a solution of Cytarabine marketed by STERIMAX INC. The full Cytarabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02515296
- Brand name
- CYTARABINE INJECTION
- Active ingredient
- Cytarabine
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- MARKETED
- Drug class
- Antimetabolite antineoplastic agent (pyrimidine analogue / antileukemic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cytarabine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02126656 | CYTARABINE INJECTION | 100 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02406772 | PMS-CYTARABINE | 100 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02406764 | PMS-CYTARABINE | 20 MG | SOLUTION | PHARMASCIENCE INC | DORMANT |